← Leaderboards
Federica Del Monte
Medical University Of South Carolina
$5,536,466
Attributed
$9,703,018
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2005–24$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$9,703,018 · 7
By mechanism
R01$8,096,575 · 4
R21$956,688 · 2
K08$649,755 · 1
Top collaborators
- Colin K Combs6 shared
- Loren Eugene Wold6 shared
- Ionita Calin Ghiran5 shared
- Zoltan P Arany2 shared
- Alexander R. Ivanov1 shared
Most similar at Medical University Of South Carolina
Same institution · by research overlap
- Ionita Calin Ghiran$12,121,941
- Warren Davis$1,563,679
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposCardiac MyocytesHeart FailureHeartMouse ModelTissuesMediatingS DiseaseLinkPathogenesisAffectIn VivoAmyloidIn VitroGeneticMyocardialGenesOrganCardiacBrainAnimal ModelNeuronsFunctional DisorderPathologic
Grant awards (24)
Red Blood Cells shuttle beta amyloid between brain and heart: implications for the pathogenesis and the progression of Alzheimer's and Cardiomyopathy$488,028
R01 · FY2024 · HL · contact PI
Red Blood Cells shuttle beta amyloid between brain and heart: implications for the pathogenesis and the progression of Alzheimer's and Cardiomyopathy$497,988
R01 · FY2023 · HL · contact PI
Red Blood Cells shuttle beta amyloid between brain and heart: implications for the pathogenesis and the progression of Alzheimer's and Cardiomyopathy$493,070
R01 · FY2022 · HL · contact PI
Effect of methodological and biological variability on molecular profiling of extracellular vesicles in cancer detection$414,671
R01 · FY2022 · CA
Mechanisms of exposure-induced tissue functional and pathological changes in a mouse model of Alzheimer's Disease$753,927
R01 · FY2021 · AG
Red Blood Cells shuttle beta amyloid between brain and heart: implications for the pathogenesis and the progression of Alzheimer's and Cardiomyopathy$502,136
R01 · FY2021 · HL · contact PI
Mechanisms of exposure-induced tissue functional and pathological changes in a mouse model of Alzheimer's Disease$761,561
R01 · FY2020 · AG
Mechanisms of exposure-induced tissue functional and pathological changes in a mouse model of Alzheimer's Disease$776,382
R01 · FY2019 · AG
Mechanisms of exposure-induced tissue functional and pathological changes in a mouse model of Alzheimer's Disease$780,611
R01 · FY2018 · AG
Mechanisms of exposure-induced tissue functional and pathological changes in a mouse model of Alzheimer's Disease$100,000
R01 · FY2018 · AG
Mechanisms of exposure-induced tissue functional and pathological changes in a mouse model of Alzheimer's Disease$817,884
R01 · FY2017 · AG
Role of Presenilin in Idiopathic Dilated Cardiomyopathy$409,979
R01 · FY2013 · HL · contact PI
Role of Presenilin in Idiopathic Dilated Cardiomyopathy$430,650
R01 · FY2012 · HL · contact PI
Identifying transcription factors that drive human cardiomyopathy$217,500
R21 · FY2012 · HL · contact PI
Role of Presenilin in Idiopathic Dilated Cardiomyopathy$435,000
R01 · FY2011 · HL · contact PI
Identifying transcription factors that drive human cardiomyopathy$261,000
R21 · FY2011 · HL · contact PI
Mechanisms of misfolded protein toxicity in idiopathic Dilated Cardiomyopathy and$261,000
R21 · FY2011 · HL · contact PI
Role of Presenilin in Idiopathic Dilated Cardiomyopathy$434,688
R01 · FY2010 · HL · contact PI
Mechanisms of misfolded protein toxicity in idiopathic Dilated Cardiomyopathy and$217,188
R21 · FY2010 · HL · contact PI
SERCA2a Abnormalities and Chaperones in Heart Failure$129,951
K08 · FY2006 · HL · contact PI
SERCA2a Abnormalities and Chaperones in Heart Failure$129,951
K08 · FY2005 · HL
SERCA2a Abnormalities and Chaperones in Heart Failure$129,951
K08 · FY2004 · HL
SERCA2a Abnormalities and Chaperones in Heart Failure$129,951
K08 · FY2003 · HL
SERCA2a Abnormalities and Chaperones in Heart Failure$129,951
K08 · FY2002 · HL